Recently, estrogens have been shown to mediate FGF2/FGFR1 paracrine activation through the G protein estrogen receptor (GPER), which coupled CAFs to breast cancer cells towards migratory and invasive tumor cell responses [9]. The gene discussed is FGFR1; the disease is breast carcinoma.